Picture of Divi's Laboratories logo

DIVISLAB — Divi's Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Divi's Labs slips on slow margin recovery

** Shares of Divi's Laboratories  DIVI.NS  fall 1.7% to
4,893 rupees
    ** Stock among top losers on Nifty 50 index  .NSEI , which
is down 1.81%
    ** DIVI saw a 21% rise in Q1 consolidated net profit,
however analysts flag slow margin recovery
    ** Co's generic API business reported a muted growth of ~1%
Y/Y, with the increase in volumes being offset by steep price
erosion, said analysts at Antique Stock Broking
    ** Continued pricing pressure in generic-APIs, overheads at
Kakinada plant and custom-synthesis project would drag margins-
Ambit Capital Research
    ** Twenty-two analysts covering the stock on avg have a
"hold" rating; median PT is 3,965 rupees - LSEG data
    ** Stock up 7% so far this qtr, vs a 10.6% rise in Nifty
pharma index  .NIPHARM  


 (Reporting by Ashna Teresa Britto in Bengaluru)
 ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))

Recent news on Divi's Laboratories

See all news